It has been about a month since the last earnings report for HCA Healthcare (HCA) . Shares have added about 10% in that time frame, outperforming the S&P 500.But investors have to be wondering, will the recent positive trend continue leading up to its next earnings release, or is HCA due for a pullback? Well, first let's take a quick look at the most recent earnings report in order to get a better handle on the recent catalysts for HCA Healthcare, Inc. before we dive into how investors and analysts have rea ...

甬兴证券有限公司研究员吴东炬、胡皓寒2025年8月26日发布研报《石头科技(688169)2025中报点评： 收入实现高增利润有望修复》称，给予公司"买入"评级。 中国经济网北京2月26日讯石头科技(688169.SH)今日收报145.30元，跌幅3.59%。 石头科技股价2025年8月27日达到当年高点222.10元。 ...

Financial Performance - Flywire (FLYW) reported break-even quarterly earnings per share, surpassing the Zacks Consensus Estimate of a loss of $0.01, compared to a loss of $0.12 per share a year ago, representing an earnings surprise of +100.00% [1] - The company posted revenues of $152.7 million for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 6.17%, and up from $112.8 million year-over-year [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.02 on revenues of $154.41 million, and for the current fiscal year, it is $0.28 on revenues of $686.21 million [7] - The estimate revisions trend for Flywire was unfavorable prior to the earnings release, resulting in a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Industry Context - The Internet - Software industry, to which Flywire belongs, is currently in the top 38% of over 250 Zacks industries, suggesting that companies in the top 50% outperform those in the bottom 50% by more than 2 to 1 [8] - Another company in the same industry, PubMatic, is expected to report a quarterly earnings decline of -61% year-over-year, with revenues projected to decrease by 12.2% from the previous year [9]

Core Viewpoint - Tennant (TNC) reported quarterly earnings of $1.39 per share, missing the Zacks Consensus Estimate of $1.68 per share, and down from $1.52 per share a year ago [1][2] Financial Performance - The earnings surprise for the quarter was -17.02%, and the company has not surpassed consensus EPS estimates over the last four quarters [2] - Revenues for the quarter were $291.6 million, missing the Zacks Consensus Estimate by 8.7%, and down from $328.9 million year-over-year [3] Stock Performance - Tennant shares have increased by approximately 13.1% since the beginning of the year, compared to a 0.9% gain in the S&P 500 [4] Future Outlook - The current consensus EPS estimate for the upcoming quarter is $1.35 on revenues of $301.05 million, and for the current fiscal year, it is $6.64 on revenues of $1.29 billion [8] - The Zacks Rank for Tennant is currently 3 (Hold), indicating expected performance in line with the market in the near future [7] Industry Context - The Manufacturing - General Industrial industry, to which Tennant belongs, is currently in the top 28% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [9]

Core Viewpoint - Domino's Pizza stock has experienced a significant pre-market rally, rising 5.94% to $407.45, despite being down 9% year-to-date [1][2]. Financial Performance - In Q4 2025, Domino's Pizza reported revenue of $1.535 billion, an increase of $90 million from Q4 2024 [3]. - The total revenue for 2025 reached $4.94 billion, which is $234 million higher than the revenue recorded in 2024 [3]. - The earnings per share (EPS) for the quarter was reported at $5.35, slightly below the forecast of $5.36 [2]. Market Reaction - The stock's rally marks a break from a downtrend, although Wall Street issued a bearish revision with a 'Sell' rating and a price target of $370, indicating a potential 9% decline [2][5]. - Despite the positive earnings reaction, Warren Buffett's Berkshire Hathaway has not seen a profitable position in DPZ, losing $32 million since the start of 2026 [6][7]. Dividend Increase - Domino's Pizza's board approved a 15% increase in dividends to $1.99 per share quarterly, which will yield approximately $7 million for Berkshire Hathaway every three months, totaling about $28 million annually [8].

分组1 - ICU Medical reported quarterly earnings of $1.91 per share, exceeding the Zacks Consensus Estimate of $1.68 per share, but down from $2.11 per share a year ago, representing an earnings surprise of +13.52% [1] - The company achieved revenues of $535.94 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 1.32%, but down from $621.62 million year-over-year [2] - ICU Medical has consistently surpassed consensus EPS estimates over the last four quarters, indicating strong performance [2] 分组2 - The stock has gained approximately 6.3% since the beginning of the year, outperforming the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the upcoming quarter is $1.78 on revenues of $522.55 million, and for the current fiscal year, it is $7.96 on revenues of $2.17 billion [7] - The Zacks Industry Rank for Medical - Products is currently in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]

Core Insights - Booking Holdings Inc reported strong fourth-quarter earnings, with earnings per share of $48.80, surpassing the analyst consensus estimate of $48.27 [1] - The company achieved quarterly sales of $6.349 billion, exceeding the analyst consensus estimate of $6.130 billion [1] - For the first quarter, Booking Holdings projects sales between $5.429 billion and $5.524 billion, compared to market estimates of $5.359 billion [1] Stock Performance - Following the earnings announcement, Booking shares increased by 3.1%, closing at $4,269.99 [2] Analyst Ratings - DA Davidson analyst Tom White maintained a Buy rating on Booking Holdings but reduced the price target from $6,600 to $6,000 [3] - BMO Capital analyst Brian Pitz maintained an Outperform rating and raised the price target from $6,000 to $6,200 [3]

Core Viewpoint - Wyndham Hotels reported quarterly earnings of $0.93 per share, exceeding the Zacks Consensus Estimate of $0.89 per share, but down from $1.04 per share a year ago, indicating an earnings surprise of +4.07% [1] Financial Performance - The company posted revenues of $334 million for the quarter ended December 2025, missing the Zacks Consensus Estimate by 1.16%, and down from $341 million year-over-year [2] - Over the last four quarters, Wyndham has surpassed consensus EPS estimates four times but has topped consensus revenue estimates only once [2] Stock Performance - Wyndham shares have increased approximately 6.3% since the beginning of the year, contrasting with the S&P 500's zero return [3] Future Outlook - The company's earnings outlook is crucial for investors, with current consensus EPS estimates at $0.90 for the coming quarter and $4.89 for the current fiscal year, with revenues expected to be $325.9 million and $1.51 billion respectively [7] - The Zacks Rank for Wyndham is currently 4 (Sell), indicating expectations of underperformance in the near future [6] Industry Context - The Hotels and Motels industry is currently in the bottom 45% of over 250 Zacks industries, suggesting that the outlook for the industry can significantly impact stock performance [8]

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...

Financial Performance - In Q4 2025, the company reported revenue of $1.318 billion, a year-over-year increase of 6.20%, and a net profit of $63 million, a significant increase of 3250%, marking a return to profitability [1] - For the full year 2025, total revenue reached $5.421 billion, up 5.73% compared to the previous year, with earnings per share (EPS) of $3.36, significantly exceeding market expectations [1] Financial Condition - The debt-to-equity ratio improved from 135.7% to 32.09% over the past five years, well below the industry average of 194.31%, indicating enhanced debt repayment capacity [2] - In Q4, operating cash flow was $205 million, with free cash flow at $171 million; for the full year, operating cash flow totaled $440 million, supporting a dividend payout of $0.68 per share and a share buyback plan of $55 million in Q2 2025 [2] Operating Status - The gross margin for Q4 was 18.82%, while the gross margin for Q3 2025 had risen to 20.33%, benefiting from optimized product mix [3] - The company's price-to-earnings (P/E) ratio was 7.38 and the price-to-sales (P/S) ratio was 0.67, both lower than the industry averages of 18.03 and 2.86, respectively, indicating relative undervaluation [3] Institutional Views - Citigroup raised its target price from $52 to $62 on January 13, 2026, maintaining a "Hold" rating; Morgan Stanley upgraded to "Buy" with a target price of $60 on December 10, 2025 [4] Stock Performance - Following the earnings report, the stock price surged by 16.57% on February 11, closing at $69.08; as of February 13, the latest stock price was $69.23, reflecting a cumulative increase of 10.34% over the past five days [5] Recent Company Status - In Q3 2025, revenue declined by 6.05% year-over-year, and EPS fell by 16.57%, primarily due to global supply chain disruptions; increased competition in the industry necessitates attention to market share differences with giants like Caterpillar and Komatsu [6]